New congressional cannabis leaders take up push for reform in 2025 (Newsletter: January 3, 2025)
From toxifillers.com with love
Feds’ PSAs embrace marijuana culture; FDA’s CBD tampon warning; NJ & CA cannabis consumption lounges; KY medical marijuana apps; NY psilocybin therapy
Subscribe to receive Marijuana Moment’s newsletter in your inbox every weekday morning. It’s the best way to make sure you know which cannabis stories are shaping the day.
Your support makes Marijuana Moment possible…
Hold on, just one second before you read today’s news. Have you thought about giving some financial support to Marijuana Moment? If so, today would be a great day to contribute. We’re planning our reporting for the coming months and it would really help to know what kind of support we can count on.
Check us out on Patreon and sign up to give $25/month today:
https://www.patreon.com/marijuanamoment
/ TOP THINGS TO KNOW
Reps. Dina Titus (D-NV) and Ilhan Omar (D-MN) are the new Democratic co-chairs of the Congressional Cannabis Caucus, replacing retiring Reps. Earl Blumenauer (D-OR) and Barbara Lee (D-CA).
The National Highway Traffic Safety Administration is leaning into marijuana culture with new anti-impaired driving PSAs pegged to 4/20, Fourth of July and other holidays—in contrast to prior government ads that peddled negative stereotypes about consumers.
The Food and Drug Administration is warning the manufacturer of a CBD tampon that its allegedly “adulterated” product is not approved for sale in the U.S. and is currently “misbranded” due to the addition of the cannabinoid.
The New Jersey Cannabis Regulatory Commission is now accepting applications for marijuana consumption lounge licenses, with social equity businesses at the front of the line.
A new California law allowing marijuana cafes took effect this week, authorizing local governments to allow cannabis retailers to expand their services—and certain businesses are already leveraging the policy change.
The Kentucky Office of Medical Cannabis is now accepting applications for medical marijuana ID cards from patients with doctors’ recommendations and from people interested in serving as caregivers for patients.
New York senators filed a bill to legalize psilocybin therapy for patients with qualifying conditions.
/ FEDERAL
Sen. Roger Wicker (R-MS) dodged a question about marijuana banking legislation.
/ STATES
A former New Jersey assemblymember said he will push lawmakers to legalize marijuana home cultivation and psilocybin therapy this year.
California regulators announced a recall of marijuana products due to the presence of aspergillus and inaccurate labeling.
Massachusetts regulators are seeking to intervene in lawsuits that marijuana businesses filed against Great Barrington.
Colorado officials are funding a new public education campaign about the risks of marijuana use.
Hawaii regulators published a medical cannabis newsletter with tips on pest management in cultivation and infusing oils and butters.
—
Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments.
Learn more about our marijuana bill tracker and become a supporter on Patreon to get access.
—
/ LOCAL
The U.S. Court of Appeals for the Ninth Circuit overturned a lower court decision that dismissed a lawsuit challenging Humboldt County, California’s code enforcement program that has resulted in penalties for alleged violations supposedly linked to cannabis cultivation.
/ INTERNATIONAL
St. Kitts and Nevis police issued a warning about marijuana-infused edibles.
/ SCIENCE & HEALTH
A study found that a “novel transdermal medical cannabis formulation (THC:CBD:CBN) demonstrated significant therapeutic efficacy in ameliorating painful [diabetic peripheral neuropathy] symptoms while maintaining a favorable safety profile.”
A review “supports psilocybin’s efficacy in treating [major depressive disorder], particularly at a 25 mg dose, showing a time-dependent therapeutic effect.”
/ BUSINESS
Grown Rogue International Inc. has a new chief financial officer.
Make sure to subscribe to get Marijuana Moment’s daily dispatch in your inbox.
Marijuana Moment is made possible with support from readers. If you rely on our cannabis advocacy journalism to stay informed, please consider a monthly Patreon pledge.
